top of page
4N8A1902
Purchased Photo - myeloid cells and CD4+
Dr Sabelo (Picture: Métro Journal)
4N8A1902
1/10
CanCURE
The Canadian HIV Cure Enterprise (CanCURE) is a research collaboratory focused on studying HIV persistence during antiretroviral therapy and developing strategies towards a sustainable HIV remission. Our innovative scientific program is supported by the Canadian Institutes of Health Research (CIHR).
CanCURE Photo Gallery
4N8A1981
4N8A1975
CanCURE AGM 2019 - Group Photo
4N8A1954
CanCURE 2019 Key Note Speaker
4N8A1902
CanCURE AGM 2019
CanCURE AGM 2019 Public Session
CanCURE AGM 2019
CanCURE AGM 2019 Poster Session
CanCURE AGM 2019
CanCURE AGM 2019 Poster Session
CanCURE AGM 2019
CanCURE AGM 2019 Poster Session
CanCURE AGM 2019
CanCURE Annual General Meeting 2017
Dr. Brendan Bell Presenting at AGM, Oct 19th, 2017, IRCM, Montreal
2017 CanCURE Group picture
Annual General Meeting, Oct 19-20th, 2017, IRCM, Montreal
AGM2017 Poster Prizes Recipients
From left to right: Tomas Raul Wiche Salinas (Centre hospitalier de l’Université de Montréal Research Center, CRCHUM), Marta Massanella (CRCHUM), Éric A Cohen (IRCM), Segen Kidane (University of Toronto), Dr. Alan Cochrane (University of Toronto), Dr. Petronela Ancuta (CRCHUM), and Dr. Nicolas Chomont (CRCHUM).
Dr Mujib
University of Toronto, 2017
Community liaison picture, 2016
1/2
Available Positions
Research Assistant or Associate
Available at the Research Institute of McGill University Health Centre (RI-MUHC) to work on CIHR-funded research studies on HIV immunology. The candidate will be supervised by Dr Cecilia Costiniuk, Associate Professor in Infectious Diseases at McGill.
Postdoctoral Fellow
Available at the Research Institute of McGill University Health Centre (RI-MUHC) to work on CIHR-funded research studies on HIV immunology. The candidate will be supervised by Dr Cecilia Costiniuk, Associate Professor in Infectious Diseases at McGill.
Postdoctoral Fellow
Human Immunodeficiency Virus (HIV)-host interactions governing HIV persistence in different models of humanized mice. Dr. Eric Cohen, Montreal Clinical Research Institute (IRCM, Montreal)
Publications
Jain et al. Bivalent SMAC mimetic APG-1387 reduces HIV reservoirs and limits viral rebound in humanized mice. iScience. November 2024
Ikeogu N, Ajibola O, Zayats R, Murooka TT. Identifying physiological tissue niches that support the HIV reservoir in T cells. mBio. September 2023
Clain et al. Early ART reduces viral seeding and innate immunity in liver and lungs of SIV-infected macaques. JCI insight. July 2023
Gantner et al. HIV rapidly targets a diverse pool of CD4+ T cells to
establish productive and latent infections. Immunity. March 2023
Colas et al. Generation of functional human T cell development in NOD/SCID/IL2rγnull humanized mice without using fetal tissue: Application as a model of HIV infection and persistence. Stem Cell Reports. February 2023
Fert et al. Targeting Th17 cells in HIV-1 remission / cure interventions. Trends in Immunology. July 2022
Tremblay et al. Bryostatin-1 Decreases HIV-1 Infection and Viral Production in
Human Primary Macrophages. Journal of Virology. February 2022
Murooka et al. T cell migration potentiates HIV infection by
enhancing viral fusion and integration. Cell Reports. February 2022
In Memory of Ron Rosenes
1947-2023
©2023 CanCURE
Follow
bottom of page